FTC reverses board bans on Hess and Sheffield, signaling a shift in regulatory approach to large mergers in the energy sector.
Elevance Health lowers profit forecast as medical costs surge, highlighting industry-wide challenges in controlling costs for government-backed health programs.
Netflix's Q2 results beat expectations, with ad revenue set to double in 2025 as its ad-supported tier reaches 94 million monthly active users.
FTC reverses board bans on Hess and Sheffield, signaling a shift in regulatory approach to large mergers in the energy sector.
Elevance Health lowers profit forecast as medical costs surge, highlighting industry-wide challenges in controlling costs for government-backed health programs.
Netflix's Q2 results beat expectations, with ad revenue set to double in 2025 as its ad-supported tier reaches 94 million monthly active users.